Healthcare · Drug Manufacturers Specialty Generic · NASDAQ
| Market cap | $2.68B |
|---|---|
| Trailing P/E | — |
| FCF yield | — |
| Revenue growth (YoY) | — |
| EPS growth (YoY) | — |
| FCF/share growth (YoY) | — |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Drug Manufacturers Specialty Generic |
Regencell Bioscience Holdings Limited trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →
| Member | Chamber | Trade | Amount | Disclosed |
|---|---|---|---|---|
| Lois Frankel | House | Sell | $1,001 - $15,000 | Jan 8, 2018 |
| Michael F Bennet | Senate | Sell | $500,001 - $1,000,000 | — |
| Gary Palmer | House | Buy | $1,001 - $15,000 | Apr 4, 2017 |
| Michael F Bennet | Senate | Sell | $500,001 - $1,000,000 | — |